Improved adequacy of levothyroxine treatment in low-risk differentiated thyroid cancer using the 2025 ATA criteria: a multicenter real-world analysis of 1,016 patients

Background: Levothyroxine titration is essential in low-risk differentiated thyroid cancer (DTC). Objective: To compare levothyroxine treatment adequacy, response distribution, and determinants of inadequacy in a large real-world cohort applying the 2015 versus 2025 American Thyroid Association (ATA...

詳細記述

書誌詳細

主要な著者:	Juan J Díez, Emma Anda, Victoria Alcazar, Juan C Galofré, Cristina Familiar, María J Pamplona-Civera, Silvia González-Martínez, Ana Herrero-Ruiz, María R Alhambra, Alejandra Planas, Cecilia Sánchez-Ragnarsson, Tomás Martín-Hernández, Beatriz Rodriguez-Jiménez, Mireia Mora, Aida Orois, Reinaldo Sánchez-Barrera, Julia Sastre
フォーマット:	Artigo
言語:	Inglês
出版事項:	Bioscientifica 2026-06-01
シリーズ:	European Thyroid Journal
主題:	differentiated thyroid cancer treatment adequacy levothyroxine therapy thyrotropin suppression dynamic risk stratification ata guidelines
オンライン･アクセス:	https://etj.bioscientifica.com/view/journals/etj/15/3/ETJ-26-0066.xml
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!